Coumadin

Coumadin is a brand name of warfarin, approved by the FDA in the following formulation(s):

COUMADIN (warfarin sodium - injectable; injection)

• 
  Manufacturer: BRISTOL MYERS SQUIBB
  
  Approval date: February 7, 1995
  
  Strength(s): 5MG/VIAL ^[RLD]

COUMADIN (warfarin sodium - tablet; oral)

• 
  Manufacturer: BRISTOL MYERS SQUIBB
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 10MG ^[RLD][AB], 2.5MG ^[AB], 2MG ^[AB], 5MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: BRISTOL MYERS SQUIBB
  
  Approval date: March 1, 1990
  
  Strength(s): 1MG ^[AB]


• 
  Manufacturer: BRISTOL MYERS SQUIBB
  
  Approval date: August 24, 1993
  
  Strength(s): 4MG ^[AB]


• 
  Manufacturer: BRISTOL MYERS SQUIBB
  
  Approval date: November 18, 1996
  
  Strength(s): 3MG ^[AB], 6MG ^[AB]

Has a generic version of Coumadin been approved?

Yes. The following products are equivalent to Coumadin:

JANTOVEN (warfarin sodium tablet; oral)

• 
  Manufacturer: USL PHARMA
  
  Approval date: October 2, 2003
  
  Strength(s): 10MG ^[AB], 1MG ^[AB], 2.5MG ^[AB], 2MG ^[AB], 3MG ^[AB], 4MG ^[AB], 5MG ^[AB], 6MG ^[AB], 7.5MG ^[AB]

warfarin sodium tablet; oral

• 
  Manufacturer: BARR
  
  Approval date: March 26, 1997
  
  Strength(s): 10MG ^[AB], 1MG ^[AB], 2.5MG ^[AB], 2MG ^[AB], 4MG ^[AB], 5MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: BARR
  
  Approval date: November 5, 1998
  
  Strength(s): 3MG ^[AB], 6MG ^[AB]


• 
  Manufacturer: INVAGEN PHARMS
  
  Approval date: May 25, 2011
  
  Strength(s): 10MG ^[AB], 1MG ^[AB], 2.5MG ^[AB], 2MG ^[AB], 3MG ^[AB], 4MG ^[AB], 5MG ^[AB], 6MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: September 27, 2004
  
  Strength(s): 10MG ^[AB], 1MG ^[AB], 2MG ^[AB], 3MG ^[AB], 4MG ^[AB], 5MG ^[AB], 6MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: September 29, 2004
  
  Strength(s): 2.5MG ^[AB]


• 
  Manufacturer: PLIVA
  
  Approval date: July 5, 2006
  
  Strength(s): 10MG ^[AB], 1MG ^[AB], 2.5MG ^[AB], 2MG ^[AB], 3MG ^[AB], 4MG ^[AB], 5MG ^[AB], 6MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: July 15, 1999
  
  Strength(s): 10MG ^[AB], 1MG ^[AB], 2.5MG ^[AB], 2MG ^[AB], 3MG ^[AB], 4MG ^[AB], 5MG ^[AB], 6MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA
  
  Approval date: May 30, 2006
  
  Strength(s): 10MG ^[AB], 1MG ^[AB], 2.5MG ^[AB], 2MG ^[AB], 3MG ^[AB], 4MG ^[AB], 5MG ^[AB], 6MG ^[AB], 7.5MG ^[AB]

Note: No generic formulation of the following product is available.

• warfarin sodium - injectable; injection

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Coumadin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Coumadin.

See also...

• Coumadin Consumer Information (Drugs.com)
• Coumadin Consumer Information (Wolters Kluwer)
• Coumadin Tablets Consumer Information (Wolters Kluwer)
• Coumadin Consumer Information (Cerner Multum)
• Coumadin Advanced Consumer Information (Micromedex)
• Coumadin Intravenous Advanced Consumer Information (Micromedex)
• Coumadin AHFS DI Monographs (ASHP)
• Warfarin Consumer Information (Drugs.com)
• Warfarin Consumer Information (Wolters Kluwer)
• Warfarin Tablets Consumer Information (Wolters Kluwer)
• Warfarin Consumer Information (Cerner Multum)
• Warfarin Advanced Consumer Information (Micromedex)
• Warfarin Intravenous Advanced Consumer Information (Micromedex)
• Warfarin Sodium AHFS DI Monographs (ASHP)